SCHEMBL22287342

SCHEMBL22287342

CC(C)CN([SiH](I)I)[SiH](I)I

nearest known ligand 0.31

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.31
MAPK1 P28482 1/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17701536 0.75 CYP1A2 (0.31) CYP1A2MAPK1CA12CA1CA2
SCHEMBL22287331 0.69 CYP1A2 (0.31) CYP1A2MAPK1CA12CA1CA2
SCHEMBL17701544 0.69 CYP1A2 (0.31) CYP1A2MAPK1CA12CA1CA2
SCHEMBL25263102 0.69 CYP1A2 (0.31) CYP1A2MAPK1CA12CA1CA2
SCHEMBL22287346 0.62
SCHEMBL14237010 0.62 CA12 (0.35) CYP1A2MAPK1CA12CA1CA2
SCHEMBL15132146 0.62 CA12 (0.35) CYP1A2MAPK1CA12CA1CA2
SCHEMBL21574005 0.60 CA12 (0.38) CYP1A2MAPK1CA12CA1CA2
SCHEMBL65000 0.60 CYP1A2 (0.53) CYP1A2MAPK1CA12CA1CA2
SCHEMBL3346122 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025226985-A1 PASSIVATION OF POLYSILICON MATERIAL AND SELECTIVE DEPOSITION OF DIELECTRIC MATERIAL UTILIZING ALKYNES VERSUM MATERIALS US, LLC (US) 2025-10-30 WO claimed
WO-2025076009-A1 SELECTIVE DEPOSITION OF SILICON CONTAINING FILMS UTILIZING ORGANOAMINOPOLYSILOXANES AND ORGANOAMINOPOLYSILAZANES VERSUM MATERIALS US, LLC (US) 2025-04-10 WO claimed
US-20230183272-A1 COMPOSITIONS AND METHODS USING SAME FOR SILICON CONTAINING FILMS VERSUM MAT US LLC (US) 2023-06-15 US claimed
US-20200247830-A1 Compositions And Methods Using Same for Silicon Containing Films VERSUM MATERIALS US, LLC (US) 2020-08-06 US claimed
US-20260130139-A1 LOW TEMPERATURE SI-CONTAINING FILMS DEPOSITED FROM CHLOROSILANE AND AMINOSILANE REACTIONS VERSUM MAT US LLC (US) 2026-05-07 US disclosed
WO-2025080587-A2 SILICON-CONTAINING FILMS HAVING SURFACES MODIFIED FROM HALOGENATED SILICON-CONTAINING COMPOUNDS VERSUM MATERIALS US, LLC (US) 2025-04-17 WO disclosed
WO-2025076009-A1 SELECTIVE DEPOSITION OF SILICON CONTAINING FILMS UTILIZING ORGANOAMINOPOLYSILOXANES AND ORGANOAMINOPOLYSILAZANES VERSUM MATERIALS US, LLC (US) 2025-04-10 WO disclosed
US-20230183272-A1 COMPOSITIONS AND METHODS USING SAME FOR SILICON CONTAINING FILMS VERSUM MAT US LLC (US) 2023-06-15 US disclosed
CN-113518834-A Compositions for silicon-containing films and methods of use thereof 弗萨姆材料美国有限责任公司 2021-10-19 CN disclosed
US-20200247830-A1 Compositions And Methods Using Same for Silicon Containing Films VERSUM MATERIALS US, LLC (US) 2020-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200247830-A1 Compositions And Methods Using Same for Silicon Containing Films SGMS1, SGMS2, SPTBN1 CYP1A2 3595/4885MAPK1 3300/4885CA12 150/4885
US-20230183272-A1 COMPOSITIONS AND METHODS USING SAME FOR SILICON CONTAINING FILMS SGMS1, SGMS2, SPTBN1 CYP1A2 3595/4885MAPK1 3300/4885CA12 150/4885
US-20260130139-A1 LOW TEMPERATURE SI-CONTAINING FILMS DEPOSITED FROM CHLOROSILANE AND AMINOSILANE REACTIONS AS3MT, SIK1, ADH1A CYP1A2 464/4885MAPK1 2207/4885CA12 1385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.